Rachel B. Salit, MD

Dr. Rachel Salit is a hematologist and oncologist, and member of the stem cell transplant faculty at Fred Hutch who focuses on improving stem cell transplant outcomes for patients who have myeloproliferative diseases. She is developing new ways to facilitate engraftment and prevent graft-vs.-host disease in patients with myelofibrosis and other myeloproliferative neoplasms. She also has an interest in improving patients’ return-to-work journey following stem cell transplant. To this end, she has developed return-to- work guidance for providers and is piloting a return-to-work support intervention.

Dr. Salit has authored multiple manuscripts in peer-reviewed journals about stem cell transplant, myelofibrosis and late-effects following stem cell transplant. Her goal is to improve outcomes for stem cell transplant patients with myelofibrosis. She has given local, national and international talks and has been featured on podcasts on the topics of stem cell transplant for myelofibrosis and returning-to-work following transplant.